Resurgence of colistin use
- 1 December 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 64 (23), 2462-2466
- https://doi.org/10.2146/ajhp060501
Abstract
Purpose. The role of colistin in the treatment of infections caused by multidrug-resistant gram-negative microorganisms is discussed.Keywords
This publication has 17 references indexed in Scilit:
- Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumanniiJournal of Infection, 2006
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infectionsThe Lancet Infectious Diseases, 2006
- The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent LiteratureClinical Medicine & Research, 2006
- Toxicity of polymyxins: a systematic review of the evidence from old and recent studiesCritical Care, 2006
- Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2005
- Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort studyIntensive Care Medicine, 2005
- Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaInternational Journal of Antimicrobial Agents, 2005
- Microbiological Activity and Clinical Efficacy of a Colistin and Rifampin Combination in Multidrug-ResistantPseudomonas aeruginosaInfectionsJournal of Chemotherapy, 2004
- Synergistic Activity of Colistin and Ceftazidime against Multiantibiotic-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2003
- In VitroInteraction of Colistin and Rifampin on Multidrug-ResistantPseudomonas aeruginosaJournal of Chemotherapy, 2003